0001144204-18-015341.txt : 20180316 0001144204-18-015341.hdr.sgml : 20180316 20180316170844 ACCESSION NUMBER: 0001144204-18-015341 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180314 FILED AS OF DATE: 20180316 DATE AS OF CHANGE: 20180316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENDHEIM JACK CENTRAL INDEX KEY: 0001241560 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 18696556 MAIL ADDRESS: STREET 1: C/O EMPIRE RESOURCES, INC. STREET 2: 1 PARKER PLAZA, SUIET 10 CITY: FORT LEE STATE: NJ ZIP: 07024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 4 1 tv488598_form4.xml FORM 4 X0306 4 2018-03-14 0 0001069899 PHIBRO ANIMAL HEALTH CORP PAHC 0001241560 BENDHEIM JACK 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666 1 1 1 0 President and CEO Class A Common Stock 2018-03-14 4 S 0 12000 40.12 D 24000 I See Class A Common Stock 2018-03-15 4 S 0 12000 39.98 D 12000 I See The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.85 to $40.55, inclusive. The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI Co., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.40 to $40.25, inclusive. /s/ Thomas G. Dagger, as Attorney-in-Fact for Jack Bendheim 2018-03-16